Structure of the ATP-binding domain of Plasmodium falciparum Hsp90

被引:54
|
作者
Corbett, Kevin D. [1 ]
Berger, James M. [1 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Quantitat Biosci Inst, Berkeley, CA 94720 USA
关键词
GHKL fold; ATPase; drug design; malaria; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; PROTEIN; HEAT-SHOCK-PROTEIN-90; INHIBITION;
D O I
10.1002/prot.22799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hsp90 is an important cellular chaperone and attractive target for therapeutics against both cancer and infectious organisms. The Hsp90 protein from the parasite Plasmodium falciparum, the causative agent of malaria, is critical for this organism's survival; the anti-Hsp90 drug geldanamycin is toxic to P. falciparum growth. We have solved the structure of the N-terminal ATP-binding domain of P. falciparum Hsp90, which contains a principal drug-binding pocket, in both apo and ADP-bound states at 2.3 angstrom resolution. The structure shows that P. falciparum Hsp90 is highly similar to human Hsp90, and likely binds agents such as geldanamycin in an identical manner. Our results should aid in the structural understanding of Hsp90-drug interactions in P. falciparum, and provide a scaffold for future drug-discovery efforts.
引用
收藏
页码:2738 / 2744
页数:7
相关论文
共 50 条
  • [41] ATP Binding to Hsp90 Is Sufficient for Effective Chaperoning of p53 Protein
    Walerych, Dawid
    Gutkowska, Malgorzata
    Klejman, Marcin P.
    Wawrzynow, Bartosz
    Tracz, Zuzanna
    Wiech, Milena
    Zylicz, Maciej
    Zylicz, Alicja
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (42) : 32020 - 32028
  • [42] Structure activity relationships in inhibitor binding to HSP90 isoforms.
    Wright, L
    Barril, X
    Dymock, B
    Drysdale, M
    Surgenor, A
    Sheridan, L
    Beswick, M
    Collier, A
    Massey, A
    Fromont, C
    Davies, N
    Sharp, S
    Workman, P
    Hubbard, RE
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6070S - 6070S
  • [43] Structure and Functional Relationships of Hsp90
    Prodromou, Chrisostomos
    Pearl, Laurence H.
    CURRENT CANCER DRUG TARGETS, 2003, 3 (05) : 301 - 323
  • [44] Hsp90: from structure to phenotype
    Jackson, SE
    Queitsch, C
    Toft, D
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (12) : 1152 - 1155
  • [45] The in silico identification of potent anti-cancer agents by targeting the ATP binding site of the N-domain of HSP90
    Sepehri, B.
    Rezaei, M.
    Ghavami, R.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2018, 29 (07) : 551 - 565
  • [46] EVIDENCE THAT THE CONSERVED REGION IN THE STEROID BINDING DOMAIN OF THE GLUCOCORTICOID RECEPTOR IS REQUIRED FOR BOTH OPTIMAL BINDING OF HSP90 AND PROTECTION FROM PROTEOLYTIC CLEAVAGE - A 2-SITE MODEL FOR HSP90 BINDING TO THE STEROID BINDING DOMAIN
    HOUSLEY, PR
    SANCHEZ, ER
    DANIELSEN, M
    RINGOLD, GM
    PRATT, WB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (22) : 12778 - 12781
  • [47] Towards a complete structure of Hsp90
    Bracher, A
    Hartl, FU
    STRUCTURE, 2005, 13 (04) : 501 - 502
  • [48] Hsp90: from structure to phenotype
    Sophie E Jackson
    Christine Queitsch
    David Toft
    Nature Structural & Molecular Biology, 2004, 11 : 1152 - 1155
  • [49] Structure and in vivo function of Hsp90
    Pearl, LH
    Prodromou, C
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2000, 10 (01) : 46 - 51
  • [50] Penicisulfuranol A, a novel C-terminal inhibitor disrupting molecular chaperone function of Hsp90 independent of ATP binding domain
    Dai, Jiajia
    Chen, Ao
    Zhu, Meilin
    Qi, Xin
    Tang, Wei
    Liu, Ming
    Li, Dehai
    Gu, Qianqun
    Li, Jing
    BIOCHEMICAL PHARMACOLOGY, 2019, 163 : 404 - 415